Literature DB >> 31316175

Molecular dynamics simulations on RORγt: insights into its functional agonism and inverse agonism.

Cong-Min Yuan1, Hai-Hong Chen1, Nan-Nan Sun1, Xiao-Jun Ma1, Jun Xu2, Wei Fu3.   

Abstract

The retinoic acid receptor-related orphan receptor (ROR) γt receptor is a member of nuclear receptors, which is indispensable for the expression of pro-inflammatory cytokine IL-17. RORγt has been established as a drug target to design and discover novel treatments for multiple inflammatory and immunological diseases. It is important to elucidate the molecular mechanisms of how RORγt is activated by an agonist, and how the transcription function of RORγt is interrupted by an inverse agonist. In this study we performed molecular dynamics simulations on four different RORγt systems, i.e., the apo protein, protein bound with agonist, protein bound with inverse agonist in the orthosteric-binding pocket, and protein bound with inverse agonist in the allosteric-binding pocket. We found that the orthosteric-binding pocket in the apo-form RORγt was mostly open, confirming that apo-form RORγt was constitutively active and could be readily activated (ca. tens of nanoseconds scale). The tracked data from MD simulations supported that RORγt could be activated by an agonist binding at the orthosteric-binding pocket, because the bound agonist helped to enhance the triplet His479-Tyr502-Phe506 interactions and stabilized H12 structure. The stabilized H12 helped RORγt to form the protein-binding site, and therefore made the receptor ready to recruit a coactivator molecule. We also showed that transcription function of RORγt could be interrupted by the binding of inverse agonist at the orthosteric-binding pocket or at the allosteric-binding site. After the inverse agonist was bound, H12 either structurally collapsed, or reorientated to a different position, at which the presumed protein-binding site was not able to be formed.

Entities:  

Keywords:  RORγt; agonism; allosteric-binding site; inverse agonism; molecular dynamics simulation; orthosteric-binding pocket; protein-binding site

Mesh:

Substances:

Year:  2019        PMID: 31316175      PMCID: PMC6961238          DOI: 10.1038/s41401-019-0259-z

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  21 in total

Review 1.  Targeting orphan nuclear receptors for treatment of metabolic diseases and autoimmunity.

Authors:  Thomas P Burris; Scott A Busby; Patrick R Griffin
Journal:  Chem Biol       Date:  2012-01-27

2.  RORc Modulators for the Treatment of Autoimmune Diseases.

Authors:  Ahmed F Abdel-Magid
Journal:  ACS Med Chem Lett       Date:  2015-08-14       Impact factor: 4.345

3.  Discovery of N-(4-aryl-5-aryloxy-thiazol-2-yl)-amides as potent RORγt inverse agonists.

Authors:  Yonghui Wang; Ting Yang; Qian Liu; Yingli Ma; Liuqing Yang; Ling Zhou; Zhijun Xiang; Ziqiang Cheng; Sijie Lu; Lisa A Orband-Miller; Wei Zhang; Qianqian Wu; Kathleen Zhang; Yi Li; Jia-Ning Xiang; John D Elliott; Stewart Leung; Feng Ren; Xichen Lin
Journal:  Bioorg Med Chem       Date:  2015-08-01       Impact factor: 3.641

4.  Structural basis for hydroxycholesterols as natural ligands of orphan nuclear receptor RORgamma.

Authors:  Lihua Jin; Dariusz Martynowski; Songyang Zheng; Taira Wada; Wen Xie; Yong Li
Journal:  Mol Endocrinol       Date:  2010-03-04

5.  The emerging landscape of RORγt biology.

Authors:  Jacob S Lee; Daniel J Cua
Journal:  Immunity       Date:  2014-04-17       Impact factor: 31.745

6.  Discovery of Biaryl Amides as Potent, Orally Bioavailable, and CNS Penetrant RORγt Inhibitors.

Authors:  Yonghui Wang; Wei Cai; Yaobang Cheng; Ting Yang; Qian Liu; Guifeng Zhang; Qinghua Meng; Fangbin Han; Yafei Huang; Ling Zhou; Zhijun Xiang; Yong-Gang Zhao; Yan Xu; Ziqiang Cheng; Sijie Lu; Qianqian Wu; Jia-Ning Xiang; John D Elliott; Stewart Leung; Feng Ren; Xichen Lin
Journal:  ACS Med Chem Lett       Date:  2015-05-26       Impact factor: 4.345

Review 7.  Retinoic Acid Receptor-Related Orphan Receptor γt (RORγt) Agonists as Potential Small Molecule Therapeutics for Cancer Immunotherapy.

Authors:  Ruomeng Qiu; Yonghui Wang
Journal:  J Med Chem       Date:  2018-02-14       Impact factor: 7.446

8.  Discovery of carbazole carboxamides as novel RORγt inverse agonists.

Authors:  Yafei Huang; Mingcheng Yu; Nannan Sun; Ting Tang; Fazhi Yu; Xiaoxia Song; Qiong Xie; Wei Fu; Liming Shao; Yonghui Wang
Journal:  Eur J Med Chem       Date:  2018-02-16       Impact factor: 6.514

9.  Retinoic acid-related Orphan Receptor γ (RORγ): connecting sterol metabolism to regulation of the immune system and autoimmune disease.

Authors:  Anton M Jetten; Yukimasa Takeda; Andrzej Slominski; Hong Soon Kang
Journal:  Curr Opin Toxicol       Date:  2018-02-01

10.  Overexpression of RORγt Enhances Pulmonary Inflammation after Infection with Mycobacterium Avium.

Authors:  Masashi Matsuyama; Yukio Ishii; Hirofumi Sakurai; Satoshi Ano; Yuko Morishima; Keigyou Yoh; Satoru Takahashi; Kenji Ogawa; Nobuyuki Hizawa
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

View more
  2 in total

1.  Delineation of the molecular determinants of the unique allosteric binding site of the orphan nuclear receptor RORγt.

Authors:  Iris A Leijten-van de Gevel; Luc Brunsveld
Journal:  J Biol Chem       Date:  2020-05-20       Impact factor: 5.157

2.  Crystallography-guided discovery of carbazole-based retinoic acid-related orphan receptor gamma-t (RORγt) modulators: insights into different protein behaviors with "short" and "long" inverse agonists.

Authors:  Ming-Cheng Yu; Feng Yang; Xiao-Yu Ding; Nan-Nan Sun; Zheng-Yuan Jiang; Ya-Fei Huang; Yu-Rong Yan; Chen Zhu; Qiong Xie; Zhi-Feng Chen; Si-Qi Guo; Hua-Liang Jiang; Kai-Xian Chen; Cheng Luo; Xiao-Min Luo; Shi-Jie Chen; Yong-Hui Wang
Journal:  Acta Pharmacol Sin       Date:  2020-11-25       Impact factor: 7.169

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.